1. Home
  2. IMRX vs BLNK Comparison

IMRX vs BLNK Comparison

Compare IMRX & BLNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRX
  • BLNK
  • Stock Information
  • Founded
  • IMRX 2008
  • BLNK 2009
  • Country
  • IMRX United States
  • BLNK United States
  • Employees
  • IMRX N/A
  • BLNK N/A
  • Industry
  • IMRX Biotechnology: Pharmaceutical Preparations
  • BLNK Industrial Specialties
  • Sector
  • IMRX Health Care
  • BLNK Consumer Discretionary
  • Exchange
  • IMRX Nasdaq
  • BLNK Nasdaq
  • Market Cap
  • IMRX 68.4M
  • BLNK 77.3M
  • IPO Year
  • IMRX 2021
  • BLNK N/A
  • Fundamental
  • Price
  • IMRX $3.38
  • BLNK $0.90
  • Analyst Decision
  • IMRX Strong Buy
  • BLNK Buy
  • Analyst Count
  • IMRX 4
  • BLNK 8
  • Target Price
  • IMRX $13.25
  • BLNK $2.61
  • AVG Volume (30 Days)
  • IMRX 2.8M
  • BLNK 4.3M
  • Earning Date
  • IMRX 08-05-2025
  • BLNK 08-06-2025
  • Dividend Yield
  • IMRX N/A
  • BLNK N/A
  • EPS Growth
  • IMRX N/A
  • BLNK N/A
  • EPS
  • IMRX N/A
  • BLNK N/A
  • Revenue
  • IMRX N/A
  • BLNK $109,383,000.00
  • Revenue This Year
  • IMRX N/A
  • BLNK N/A
  • Revenue Next Year
  • IMRX N/A
  • BLNK $31.15
  • P/E Ratio
  • IMRX N/A
  • BLNK N/A
  • Revenue Growth
  • IMRX N/A
  • BLNK N/A
  • 52 Week Low
  • IMRX $1.00
  • BLNK $0.63
  • 52 Week High
  • IMRX $3.87
  • BLNK $3.75
  • Technical
  • Relative Strength Index (RSI)
  • IMRX 69.21
  • BLNK 52.59
  • Support Level
  • IMRX $2.29
  • BLNK $0.89
  • Resistance Level
  • IMRX $3.87
  • BLNK $0.98
  • Average True Range (ATR)
  • IMRX 0.44
  • BLNK 0.08
  • MACD
  • IMRX 0.10
  • BLNK -0.00
  • Stochastic Oscillator
  • IMRX 77.72
  • BLNK 37.89

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

About BLNK Blink Charging Co.

Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns a majority of revenue from U.S.A.

Share on Social Networks: